Tci Wealth Advisors, Inc. Macrogenics Inc Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$2.25 - $9.99 $981 - $4,355	-436 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$8.12 - $16.9 $1,339 - $2,788	165 Added 60.89%	436 $4,000
Q4 2021 Jan 24, 2022	BUY	$15.91 - $21.88 $1,956 - $2,691	123 Added 83.11%	271 $4,000
Q3 2021 Oct 29, 2021	BUY	$19.74 - $28.7 $2,921 - $4,247	148 New	148 $3,000
Q2 2021 Aug 02, 2021	SELL	$20.49 - $35.63 $1,618 - $2,814	-79 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$18.99 - $33.2 $1,500 - $2,622	79 New	79 $3,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.